Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Heart rate and the funny channel
In the normal heart the sinus node determines the heart rate.1 Sino-atrial myocytes are characterised by a poorly developed contractile system and self-generating repetitive action potentials, a feature not found in the myocytes of cardiac muscle. At the end of the action potential, depolarisation of the membrane voltage continues, during phase four, until this triggers another action potential. While sino-atrial myocytes are heavily innervated by both sympathetic and vagal nerves, the spontaneous activity is independent of innervation. The mechanisms controlling, or modifying, these spontaneous diastolic depolarisations are central to interventions that might be employed to modify heart rate. Early thinking attributed pacemaker activity to the decay of an outward K+ current, but in the late 1970s Brown et al identified, to their surprise, a new likely inward current accordingly described as a ‘funny current or If’.2
Although many questions remain unanswered,3 If is now recognised as an Na/K inward current activated by hyperpolarisation and modulated by the autonomic nervous system. Adrenaline induced rate acceleration in sino-atrial myocytes is almost entirely due to shortening of the diastolic duration with minimal effect on action potential shape and duration2 in contrast to adrenalin-mediated influences on cardiac action potentials elsewhere. Vagal influences are similarly associated with slowing of phase four of the sino-atrial myocytes rather than influencing the morphology elsewhere. There appears to be upregulation of the If channel in cardiac hypertrophy and heart failure (HF).4 ,5
But why might this be of interest?
While there is extensive evidence that a slower heart rate is associated with better outcomes, be that as a marker of overall fitness in the general population,6 ,7 in people with a range of cardiovascular conditions,8–10 in HF specifically,11 ,12 or to the diverse therapeutic effects of β-blockers in HF,13 , …
Competing interests The author contributed to NICE STA as one of a number of Clinical Specialists, having been nominated by the Royal College of Physicians,and was earlier a member of the GDG for Chronic Heart Failure (2010). As Chair to the British Society for Heart Failure (BSH), 2011-13, and a current BSH Board member, potential indirect COI arise with a range of companies, listed on the BSH website, including Servier, whose grants and other contributions support BSH activities.
Provenance and peer review Commissioned; internally peer reviewed.